We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Study Identifies Several Existing Drugs As Potential COVID-19 Therapies

Video   Jun 04, 2021 | Taken from Scripps Research, YouTube

 

Mining the world’s most comprehensive drug repurposing collection for COVID-19 therapies, scientists have identified 90 existing drugs or drug candidates with antiviral activity against the coronavirus that’s driving the ongoing global pandemic.

Among those compounds, the Scripps Research study identified four clinically approved drugs and nine compounds in other stages of development with strong potential to be repurposed as oral drugs for COVID-19, according to results published June 3 in the journal Nature Communications.

Of the drugs that prevented the coronavirus from replicating in human cells, 19 were found to work in concert with or boost the activity of remdesivir, an antiviral therapy approved for treatment of COVID-19.

“While we now have effective vaccines against COVID-19, we still lack highly effective antiviral drugs that can prevent COVID-19 infections or stop them from worsening,” says Peter Schultz, PhD, President and CEO of Scripps Research.

“Our results raise the possibility of a number of promising avenues for repurposing existing oral medications with efficacy against SARS-CoV-2,” he adds. “We have identified promising existing drugs and are also leveraging our findings to develop optimized antivirals that will be more effective against SARS-CoV-2, including variants and drug-resistant strains, as well as against other coronaviruses that currently exist or might emerge in future.”



 
 
 
Advertisement
 

Recommended Videos

Potential Therapeutic Uses of Cannabinoids With Professor Roger Pertwee

Video

Much of what we know about the cannabis plant and its effects on the human body has only been formally discovered in the past 60 years. A good deal of these pioneering investigations have involved today's Teach Me in 10 guest: Roger Pertwee, an emeritus professor at the University of Aberdeen.

WATCH NOW

Amersham™ brand ImageQuant™ 800 GxP biomolecular imager – Cytiva

Video

Sensitive, flexible CCD-based imagers designed to support FDA 21 CFR Part 11 EU GMP Annex 11 regulations

WATCH NOW

Disease Modeling Using ALI Tools and Systems

Video

Join this Teach Me in 10 session to hear Corning Life Sciences Digital Manager Roxana Ghadessy and Corning Life Sciences Product Line Manager Shabana Islam talk to us about disease modeling using ALI tools and systems.

WATCH NOW

 

Like what you just watched? You can find similar content on the communities below.

Biopharma Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE